Centricity Wealth Management LLC Invests $47,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Centricity Wealth Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 91 shares of the medical equipment provider’s stock, valued at approximately $47,000.

Other hedge funds have also bought and sold shares of the company. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $36,000. Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the third quarter worth $38,000. Finally, DT Investment Partners LLC boosted its holdings in Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $591.79 on Friday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock has a market capitalization of $210.78 billion, a PE ratio of 92.32, a price-to-earnings-growth ratio of 5.87 and a beta of 1.39. The firm has a 50 day simple moving average of $565.45 and a 200-day simple moving average of $524.52.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock worth $3,587,582 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent research reports. Leerink Partners raised their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Evercore ISI raised their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Citigroup upped their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. CICC Research assumed coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. Finally, UBS Group upped their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.